Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,359
Closed -$365K 273
2025
Q3
$365K Hold
13,359
﹤0.01% 247
2025
Q2
$386K Sell
13,359
-86,657
-87% -$2.46M ﹤0.01% 248
2025
Q1
$2.88M Sell
100,016
-136,708
-58% -$5.16M ﹤0.01% 234
2024
Q4
$10.6M Sell
236,724
-18,601
-7% -$878K 0.01% 210
2024
Q3
$11.3M Sell
255,325
-8,909
-3% -$365K 0.01% 209
2024
Q2
$10.2M Buy
264,234
+41,965
+19% +$1.72M 0.01% 211
2024
Q1
$10.9M Sell
222,269
-8,292
-4% -$398K 0.01% 223
2023
Q4
$11.2M Sell
230,561
-5,731
-2% -$255K 0.01% 214
2023
Q3
$9.63M Sell
236,292
-2,521
-1% -$99.9K 0.01% 216
2023
Q2
$9.46M Buy
238,813
+35,452
+17% +$1.28M 0.01% 217
2023
Q1
$8.27M Sell
203,361
-5,413
-3% -$199K 0.01% 227
2022
Q4
$6.89M Buy
208,774
+45,126
+28% +$1.35M 0.01% 237
2022
Q3
$4.44M Buy
163,648
+2,340
+1% +$71.3K ﹤0.01% 242
2022
Q2
$4.62M Buy
161,308
+21,544
+15% +$817K ﹤0.01% 236
2022
Q1
$7.23M Buy
139,764
+71
+0.1% +$3.65K 0.01% 244
2021
Q4
$9.39M Buy
139,693
+4,275
+3% +$308K 0.01% 249
2021
Q3
$9.89M Buy
135,418
+21,483
+19% +$1.58M 0.01% 250
2021
Q2
$6.75M Buy
113,935
+83,735
+277% +$4.28M ﹤0.01% 254
2021
Q1
$1.3M Buy
+30,200
New +$1.49M ﹤0.01% 261

Other funds holding DCBO

Baillie Gifford & Co's DCBO Position: Q4 2025 in Review

Baillie Gifford & Co sold out of Docebo (DCBO) in Q4 2025, closing a stake of 13,359 shares — an estimated $365K sold.

Baillie Gifford & Co first reported a position in DCBO in Q1 2021 and held it in 19 quarters. The position peaked at $11.3M in Q3 2024. 83 funds tracked by Wall St. Rank hold DCBO as of Q4 2025.

  • Baillie Gifford & Co reported no remaining Docebo position as of Q4 2025 after selling out during the quarter.
  • Baillie Gifford & Co sold 13,359 Docebo shares in Q4 2025, an estimated $365K.
  • Baillie Gifford & Co first reported a position in Docebo in Q1 2021 and held it in 19 quarters.
  • Baillie Gifford & Co's Docebo position peaked at $11.3M in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Docebo as of Q4 2025.

Based on Baillie Gifford & Co's 13F filing for Q4 2025, filed 23 Jan 2026.